International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Special Issue 3 doi: 10.5281/zenodo.8201880
Original Article
An Updated Review (Phytochemistry, Antimicrobial Pharmacology) on Indigenous King of Bitter (Andrographis Paniculata)
 ,
 ,
 ,
 ,
 ,
 ,
Abstract

Andrographis paniculata (King of Bitters), also known as Kalmegh, is a member of the Acanthaceae family. Andrographis paniculata is widely cultivated, and its relevance as a medicinal plant is expanding as evidence of its several therapeutic applications grows. Considering the plant's beneficial properties, it might be recommended as a safe and vital medicinal herb for mankind. This herb is rich in chemical components, including lactones, diterpenoids, diterpene glycosides, flavonoids, and flavonoid glycosides. It possesses numerous pharmacological effects, including antibacterial, hepatoprotective, anti-cancer, anticancer, hypoglycemic, immunomodulatory, and hypotensive action. The goal of this study is to conduct a literature review on Andrographis paniculata, specifically papers on therapeutic advantages, chemical features, and pharmacological evaluation. It is widely utilised as a home cure for numerous maladies in the Bangladeshi traditional system of medicine. Steroids, phenols, terpenoids, alkaloids, saponins, and flavonoids were the active chemicals found in Andrographis paniculata. The presence of active components, andrographolide and neoandrographolide, which are diterpenoids derivatives, contributes to the therapeutic potential of this plant.

Recommended Articles
Loading Image...
Volume-4, Special Issue 3
Citations
2082 Views
101 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved